Cargando…
Genome‐scale metabolic modeling reveals SARS‐CoV‐2‐induced metabolic changes and antiviral targets
Tremendous progress has been made to control the COVID‐19 pandemic caused by the SARS‐CoV‐2 virus. However, effective therapeutic options are still rare. Drug repurposing and combination represent practical strategies to address this urgent unmet medical need. Viruses, including coronaviruses, are k...
Autores principales: | Cheng, Kuoyuan, Martin‐Sancho, Laura, Pal, Lipika R, Pu, Yuan, Riva, Laura, Yin, Xin, Sinha, Sanju, Nair, Nishanth Ulhas, Chanda, Sumit K, Ruppin, Eytan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8552660/ https://www.ncbi.nlm.nih.gov/pubmed/34709707 http://dx.doi.org/10.15252/msb.202110260 |
Ejemplares similares
-
Genome-scale metabolic modeling reveals SARS-CoV-2-induced metabolic changes and antiviral targets
por: Cheng, Kuoyuan, et al.
Publicado: (2021) -
Synthetic lethality-based prediction of anti-SARS-CoV-2 targets
por: Pal, Lipika R., et al.
Publicado: (2021) -
Synthetic lethality-based prediction of anti-SARS-CoV-2 targets
por: Pal, Lipika R., et al.
Publicado: (2022) -
Synthetic lethality across normal tissues is strongly associated with cancer risk, onset, and tumor suppressor specificity
por: Cheng, Kuoyuan, et al.
Publicado: (2021) -
Cross-species identification of cancer resistance–associated genes that may mediate human cancer risk
por: Nair, Nishanth Ulhas, et al.
Publicado: (2022)